Associate Professor Neuen is an internationally recognized expert on the efficacy and safety of SGLT2 inhibitors. He is a Staff Specialist Nephrologist and Director, Kidney Trials Unit at Royal North Shore Hospital and Senior Research Fellow at The George Institute, Australia. Dr. Neuen serves as the founding Secretariat of the SGLT2 Meta-Analysis Cardio-Renal Trialists’ Consortium (SMART-C). He is involved in the leadership of multiple ongoing international multi-centre randomized trials. His work has directly informed both KDIGO Guidelines and American Diabetes Association Standards of Care.
